Brokers' take

Fu Yu Corp | Buy (maintained) July 9 close: S$0.215 Target price: S$0.24 RHB Research Institute, July 9

With the ramp-up in its existing projects set to continue in subsequent quarters, coupled with further new projects on the medical and consumer, and automotive front, we expect the positive growth momentum of Fu Yu Corp to continue.

In addition, with more than 80 per cent of revenue received in US dollar terms, an appreciating greenback should also be beneficial to the company.